Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of High Concentration(2%) Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis

NCT05911503 is registered in ClinicalTrials.gov with Tianjin Medical University as lead sponsor.

NCT NCT05911503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05911503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of High Concentration(2%) Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
Lead sponsor
Tianjin Medical University
Phase
Phase 1
Overall status
Recruiting
Start date
July 1, 2023
Completion date
June 30, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus retinitis, ganciclovir eye drops